Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-alfa in patients with metastatic melanoma: a randomized proof-of-principle phase II study.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Dendritic cell vaccines (Primary) ; Aldesleukin; Interferon alpha
- Indications Malignant melanoma
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- Acronyms ABSIDE
- 26 Feb 2021 Biomarkers information updated
- 26 Jun 2013 New trial record